This is a routine executive hiring grant with no immediate read-through for operations or pipeline. Monitor for any strategic updates from the new CMO in future earnings calls or clinical milestones.
Price Chart
Executive Summary
Intellia Therapeutics awarded inducement equity grants to its new Chief Medical Officer, Jing Marantz, consisting of options for 275,061 shares and RSUs for 199,822 shares, as a material inducement to employment. The awards are routine compensation for a key executive hire and do not reflect any change in the company's financial or operational outlook.
Key Facts
- Inducement grants awarded to new CMO Jing Marantz on October 26, 2026
- Option award: 275,061 shares at $11.26 exercise price, vesting over 3 years
- RSU award: 199,822 shares, vesting in three equal annual installments
- Grants made under Intellia's 2024 Inducement Plan, approved by independent directors
- Awards are a material inducement to employment per Nasdaq Listing Rule 5635(c)(4)
Financial Impact
Equity grants of 474,883 total shares (options + RSUs) represent approximately 0.5% of shares outstanding based on market cap of $1.6B and stock price of $11.26; no cash consideration.
Risk Factors
- No material risk identified; the grants are standard inducement compensation for a new executive hire.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3390758 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 2d ago | Press Release | $13.23 | awaiting T+5 | awaiting T+5 | $12.47 (−5.74%) |
Oct 28, 2026 2d ago | 3 | $13.23 | awaiting T+5 | awaiting T+5 | $12.47 (−5.74%) |
Oct 2, 2026 28d ago | Press Release | $12.75 $12.58 | ▼ −1.33% | ▼ −1.76% | $12.47 (−2.20%) |
Sep 8, 2026 7w ago | 8-K | $12.21 $11.60 | ▼ −5.00% | ▼ −4.66% | $12.47 (+2.13%) |
Aug 6, 2026 12w ago | 8-K | $11.24 $11.83 | ▲ +5.25% | ▲ +4.04% | $12.47 (+10.94%) |
Jun 15, 2026 19w ago | 8-K | $14.92 $15.75 | ▲ +5.56% | ▲ +6.95% | $12.47 (−16.42%) |
Jun 13, 2026 19w ago | Press Release | $14.92 $15.75 | ▲ +5.56% | ▲ +6.95% | $12.47 (−16.42%) |
Jun 1, 2026 21w ago | Press Release | $13.73 $13.54 | ▼ −1.38% | ▲ +1.37% | $12.47 (−9.18%) |
May 11, 2026 24w ago | 8-K | $14.42 $12.69 | ▼ −12.00% | ▼ −11.91% | $12.47 (−13.52%) |
Apr 27, 2026 26w ago | Press Release | $13.20 $13.87 | ▼ −5.08% | ▼ −3.38% | $12.47 (+5.53%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers